Similar Posts
Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04, for the Treatment of Patients with Moderate to Severe Osteoarthritis – Bio Tech Winners
August 6, 2024 by Leave a Comment Last Updated on August 6, 2024 by [#item_full_content] Like this: Like Loading… Related Filed Under: biotech news, News Reader Interactions This site uses Akismet to reduce spam. Learn how your comment data is processed. Source link
M&M outpaces industry with 10.5% Q1 growth, gains market share across segments, says Siddhartha Khemka
India’s tractor industry posted a healthy 9.2% YoY growth in Q1FY26, delivering 2.86 lakh units, driven by robust demand in the high-horsepower (HP) categories and pre-season stocking ahead of the Kharif sowing period. Favourable Rabi harvest earnings and steady demand from key agricultural states underpinned the strong start to the fiscal year. The 41–50HP segment…
Dividend Investors: 1 Top Canadian Utility Stock to Buy for September
Utility stocks in Canada are like the steady heartbeat of a well-balanced investment portfolio. They might not be the most glamorous picks. But they are reliable, providing consistent returns year after year. The beauty of utility stocks lies in their stability. People need electricity, water, and gas regardless of economic ups and downs, which means…
PTX – Prescient Therapeutics
Thanks Prawn.. I have just learnt how to PM, so kool mate!. They don’t have it in HC Anyway VHL = Virax … a small Aussie underdog biotech company with a HIV Therapeutic VIR201 that is currently undergoing phase 2b trial South Africa. VIR201 is using Virax’s Co-X-Gene technology. The same technology that has been…
